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Abstract:  The application of  benzo(a)pyrene  (BaP)-toxic equivalent  factor to polycyclic 
aromatic hydrocarbons (PAH) concentrations can provide a more accurate risk assessment 
from  environmental  exposure  to  PAH.  We  hypothesized  that  BaP-equivalent  toxicity 
determined following residential air monitoring among young urban children may vary by 
season. Residential indoor and outdoor air levels of PAH measured over two-weeks in a 
cohort of 5–6 year old children (n = 260) in New York City were normalized to the cancer 
and mutagen potency equivalent factor of BaP (BaP = 1). Data are presented as carcinogenic 
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equivalents  (BaP-TEQ)  and  mutagenic  equivalents  (BaP-MEQ)  for  the  sum  of  8  PAH 
(8PAH; MW  228) and individual PAH and compared across heating versus nonheating 
seasons.  Results  show  that  heating  compared  to  nonheating  season  was  associated 
significantly with higher (BaP-TEQ)∑8PAH and (BaP-MEQ)∑8PAH both indoors and outdoors 
(p < 0.001). Outdoor (BaP-TEQ)∑8PAH and (BaP-MEQ)∑8PAH were significantly higher than 
the corresponding indoor measures during the heating season (p < 0.01). These findings 
suggest that at levels encountered in New York City air, especially during the heating season, 
residential exposure to PAH may pose an increased risk of cancer and mutation. 
Keywords:  risk assessment; PAH; BaP-equivalents; TEF; MEF; heating season; indoor; 
outdoor; and children 
 
1. Introduction  
Many  polycyclic  aromatic  hydrocarbons  (PAH)  are  suspected  or  known  carcinogens  and  
mutagens [1-3]. Benzo(a)pyrene (BaP), believed to be the most toxic PAH, has been well-characterized 
toxicologically.  However,  less  information  is  available  for  most  of  the  other  PAH.  In  most  risk 
assessments, many individual PAH have been considered to be of equivalent toxicity as BaP [4]. This 
approach could result in the overestimation of cancer and mutagen potency of individual PAH because 
most PAH are considerably less toxic than BaP when analyzed in the same assay systems (e.g., mouse 
skin, human cell mutagenicity assays) [1-3,5].  
Several approaches have been developed to obtain a more accurate assessment of potential risk of 
exposure to a complex mixture of PAH using toxic equivalency factors based on BaP [1-3,6-8]. One is 
the  carcinogenic  equivalency  factors  (TEF)  that  can  vary  at  either  low  or  high  dose  settings.  For 
example, TEF of dibenz(ah)anthracene (DahA) is around 5 at low dose and close to 1 at higher dose 
based on local tumors induced by subcutaneous injection into mice [9]. Mutagenicity of individual 
PAH relative to BaP also has been assessed using the mutagenic equivalency factor (MEF) proposed by 
Durant et al. [1,2]. Mutagenic activity, while not as uniformly associated with cancer [10-12], may 
have implications for other non-cancerous adverse health effects, such as pulmonary diseases [13,14].  
TEF and MEF values in combination with measured air concentrations have been used for the 
calculation of carcinogenic equivalents (TEQ, expressed in ng/m
3) and mutagenic equivalents (MEQ, 
expressed in ng/m
3) in environmental samples [15-17]. To date, these studies have yielded important 
reassessments of the contributions of exposure to PAH, including those derived from traffic emissions, 
on lung cancer risk [17]. However, most pediatric cohort research that addresses the adverse health 
effects of exposure to air pollution, and PAH specifically, have compared levels of airborne PAH, or 
their metabolites, with clinical outcomes [18]. Use of the TEQ or MEQ may lead to a more accurate 
assessment of potential health risk in a pediatric cohort.  
We  hypothesized  that  BaP-equivalent  toxicity,  when  assessed  using  residential  monitoring  in  a 
pediatric  urban  cohort,  varies  by  season  due  to  higher  emissions  from  heating  sources  and  more 
frequent stagnant meteorological conditions in the winter. Our approach was to calculate BaP-TEQ and Int. J. Environ. Res. Public Health 2010, 7                 
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BaP-MEQ to estimate residential indoor and outdoor PAH carcinogenic and mutagenic hazards in 
young inner city children, known to be at greater risk for adverse health consequences from exposure to 
air pollution [18-20]. BaP-TEQ is based specifically on the report by Nisbet and Lagoy [3] and was 
determined at relatively low doses compared to other reports and may be an more appropriate method 
for reassessing the potential risk of airborne exposure to PAH in urban settings [3,6,7]. 
2. Experimental Section  
Study design. Children were primarily of African-American and Dominican ethnicity and lived in 
Northern Manhattan and the South Bronx, geographical areas where exposure to traffic-related air 
pollution  has  been  implicated  in  asthma  and  other  diseases  [19].  260  children  from  the  parent 
Columbia Center for Children’s Environmental Health (CCCEH) cohort study was included in this 
analysis [18,20] if they were age 5–6 years beginning October 2005 and resided in Northern Manhattan 
and the South Bronx during pregnancy and continued to live in Northern Manhattan and the Bronx at 
enrollment as described [21]. The study was approved by the Columbia University Institutional Review 
Board and informed consent obtained. 
Residential monitoring. Boxes containing up to three vacuum pumps and valves to control flow 
were used to collect two-week integrated indoor and outdoor PAH samples at each of 260 homes 
between October 2005 and May 2009. Indoor air monitors were placed in a room where the child spent 
most of his or her time (e.g., child’s bedroom or main living area of the apartment), at a height of about 
1.2 m and at least 0.3 m from the walls. At one third of homes, selected randomly but evenly across all 
4 meteorological seasons, simultaneous outdoor sampling was conducted by placing samplers out of 
windows securely hung 0.9 m from the outside wall with a window unit that was designed so as not to 
appreciably  affect  air  exchange  rates  of  the  apartment  (i.e.,  subject  can  have  the  window  open  
or closed).  
Particulate  phase  of  PAH  on  a  quartz  microfiber  filter  was  collected  in  a  cassette  attached 
downstream from a cyclone with a 2.5 m aerodynamic-diameter cut point (model SCC 1.062, BGI, 
Inc.). Gas phases of PAH were collected on polyurethane foam (PUF) cartridge back-up, as previously 
described [21,22]. The residential air sampling pumps operated continuously at 1.5 L/min for two 
weeks, leading to an average sampling volume of 30.1 m³ . The air flow rates were checked at the 
beginning and end of sampling to ensure that a constant flow rate was maintained throughout the 
sampling period. Eight 4-ring to 6-ring PAH were selected as target compounds due to their abundance 
in  traffic  emissions  and  their  possible  carcinogenicity  and  mutagenicity  [23,24].  The  eight  PAH 
monitored  were:  benz[a]anthracene  (BaA),  chrysene/iso-chrysene  (Chry),  benzo[b]fluoranthene 
(BbFA),  benzo[k]fluoranthene  (BkFA),  benzo[a]pyrene  (BaP),  indeno[1,2,3-c,d]pyrene  (IP), 
dibenz[a,h]anthracene (DahA), benzo[g,h,i]perylene (BghiP). A single soxhlet extraction of both the 
filters  and  PUFs  together  was  analyzed  at  Southwest  Research  Institute  (San  Antonio,  TX)  as  
described  [23].  Two  deuterated  compounds  (anthracene-d10  and  p-terphenyl-d14)  were  used  as 
surrogate  standards  for  recovery  and  chrysene-d12  and perylene-d12  were used as  internal  standard  
for quantification.  
Calculation of BaP-equivalent concentrations. BaP-TEQ (carcinogenic equivalents, ng/m³ ) and 
BaP-MEQ (mutagenic equivalents, ng/m³ ) were calculated by multiplying the concentrations of each Int. J. Environ. Res. Public Health 2010, 7                 
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PAH compound with its TEF for cancer potency relative to BaP [3] and MEF relative to BaP [1-2], 
respectively. BaP-TEQ and BaP-MEQ levels for the sum of nonvolatile PAH (8PAH; MW228) 
were calculated as follows: 
  (BaP-TEQ)∑8PAH = [BaA]  0.1 + [Chry]  0.01 + [BbFA]  0.1 + [BkFA]  0.1 + [BaP]  1 + 
[IP]  0.1 + [DahA]  5 + [BghiP]  0.01. 
  (BaP-MEQ)∑8PAH = [BaA]  0.082 + [Chry]  0.017 + [BbFA]  0.25 + [BkFA]  0.11 + [BaP] 
 1 + [IP]  0.31 + [DahA]  0.29 + [BghiP]  0.19. 
Quality control. Each air monitoring result was assessed and flagged if there are any issues of 
sampling conditions such as tube disconnection from the pump, late-takedown, pump failure, switch 
error, and any other human errors. Once flagged, air monitoring data were given a quality assurance 
(QA) score of 1 (0: highest quality) and further examined for additional score for erroneous length of 
sampling time, erroneous flow rate of pump, and missing documentation. If a final QA score is ≥ 3, the 
data was excluded, sampling was redone. Flagged data were included for analysis if they passed a 
quality control test (QA  2), as described [25]. Five failed the quality control test. 
Mean recovery of deuterated surrogate standards was 97.9% (17% Standard deviation, SD) and 
102.6% (15%, SD) for d10 anthracene and d14-p-terphenyl, respectively in all batches except for one. 
In one batch of measures, the mean recovery efficiency exceeded 130% in some samples (attributed to 
evaporation  during  storage)  and  adjustment  was  made  downward  by  the  multiplier  100/  (mean 
recovery) and included for the data analysis. The limit of detection (LODs) for 8 individual PAH was 
0.03 ng/m
3.  
Statistical analysis. Descriptive statistics were used to describe overall BaP-TEQ and BaP-MEQ 
concentrations  for  individual  PAH  and  8PAH  indoors  and  outdoors.  Due  to  the  non-normal 
distributions of individual PAH and the sum of 8 PAH (8PAH) concentrations, Mann-Whitney and 
Wilcoxon signed ranks test were conducted. Heating season was defined as any sampling that was 
initiated October 1st through April 30st as described [21]. Indoor and outdoor comparisons were based 
on  the  subset  of  homes  in  which  both  indoor  and  outdoor  air  concentrations  were  measured 
simultaneously. Analyses were conducted using SPSS software (SPSS; Chicago, IL, version 17).  
3. Results 
Residential indoor and outdoor BaP-equivalents 
 
The BaP-equivalent (BaP-TEQ and BaP-MEQ) concentrations calculated for 8PAH and individual 
PAH  measured  in  this  study  are  shown  in  Table  1.  The  levels  of  indoor  (BaP-TEQ)∑8PAH  and  
(BaP-MEQ)∑8PAH  ranged  from  0.098–8.348  ng/m
3  and  0.069–19.72  ng/m
3,  respectively.  For  all 
samples studied, the largest contribution of individual PAH to (BaP-TEQ)∑8PAH and (BaP-MEQ)∑8PAH 
was made by BaP, followed by DahA for (BaP-TEQ)∑8PAH and IP and BghiP for (BaP-MEQ)∑8PAH 
(Table 1). In outdoor air, the contribution of BbFA to (BaP-MEQ)∑8PAH was substantially elevated 
when compared to indoor air, making it the dominant compound contributing to (BaP-MEQ)∑8PAH. Int. J. Environ. Res. Public Health 2010, 7                 
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Table 1. BaP-equivalent carcinogenicity and mutagenicity risks assessed in 5–6 year old residential indoor and outdoor air. 
  BaP-TEQ Levels, ng/m
3    BaP-MEQ Levels, ng/m
3 
Analyte  n 
aTEF  Median  Mean  SD  Range   
bMEF  Median  Mean  SD  Range 
∑8PAH  255  NA  0.299  0.478  0.709  0.098-8.348    NA  0.376  0.590  1.325  0.069-19.72 
BaP  255  1  0.121  0.198  0.363  0.015-4.494    1  0.121  0.198  0.363  0.015-4.494 
BaA  255  0.1  0.006  0.009  0.010  0.002-0.132    0.082  0.005  0.007  0.009  0.001-0.108 
Chry  255  0.01  0.001  0.001  0.002  0.000-0.021    0.017  0.001  0.002  0.003  0.000-0.036 
BbFA  255  0.1  0.019  0.028  0.034  0.004-0.346    0.25  0.047  0.069  0.084  0.010-0.865 
BkFA  255  0.1  0.006  0.010  0.013  0.002-0.140    0.11  0.007  0.010  0.014  0.002-0.154 
IP  255  0.1  0.028  0.044  0.094  0.002-1.400    0.31  0.087  0.136  0.291  0.006-4.340 
DahA  255  5  0.083  0.180  0.212  0.055-1.741    0.29  0.005  0.010  0.012  0.003-0.101 
BghiP  255  0.01  0.004  0.008  0.033  0.001-0.517    0.19  0.084  0.156  0.624  0.016-9.828 
Outdoor                       
∑8PAH  82  NA  0.277  0.450  0.389  0.109-1.932    NA  0.360  0.528  0.454  0.062-2.394 
BaP  82  1  0.091  0.133  0.133  0.016-0.748    1  0.091  0.133  0.133  0.016-0.748 
BaA  82  0.1  0.007  0.011  0.011  0.001-0.059    0.082  0.005  0.009  0.009  0.001-0.048 
Chry  82  0.01  0.001  0.002  0.002  0.0003-0.008    0.017  0.002  0.004  0.003  0.001-0.013 
BbFA  82  0.1  0.039  0.048  0.043  0.006-0.237    0.25  0.097  0.121  0.108  0.015-0.592 
BkFA  82  0.1  0.010  0.015  0.017  0.002-0.114    0.11  0.011  0.017  0.018  0.002-0.125 
IP  82  0.1  0.027  0.035  0.031  0.003-0.197    0.31  0.085  0.107  0.095  0.010-0.611 
DahA  82  5  0.083  0.199  0.188  0.075-1.021    0.29  0.005  0.012  0.011  0.004-0.059 
BghiP  82  0.01  0.005  0.007  0.007  0.001-0.039    0.19  0.087  0.126  0.126  0.010-0.739 
aTEF: toxic equivalency factors for cancer potency relative to BaP (Nisbet and LaGoy, 1992) 
bMEF: mutagenic potency factor relative to BaP (Durant et al., 1996 and 1999) 
BaP-TEQ: Carcinogenic equivalents calculated from the cancer potency relative to BaP (TEF) multiplied by the concentration of PAH in a sample. 
BaP-MEQ: Mutagenic equivalents calculated from the mutagenic potency relative to BaP (MEF) multiplied by the concentration of PAH in a sample.  
8PAH  includes  benzo(a)pyrene  (BaP), benz(a)anthracene (BaA), chrysene/iso-chrysene (Chry), benzo(b)fluoranthene (BbFA), benzo(k)fluoranthene (BkFA), indeno(1,2,3-
c,d)pyrene (IP), dibenz(a,h)anthracene(DahA), and benzo(ghi)perylene(BghiP). 
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Seasonal variations in BaP-equivalents 
 
Heating compared to nonheating season was associated significantly with higher (BaP-TEQ)∑8PAH and (BaP-MEQ)∑8PAH both indoors and outdoors 
(Figure 1-a and Figure 1-b; p < 0.001, Mann-Whitney test). This pattern was apparent when the individual 8 PAH were assessed (p < 0.001).  
In  addition,  during  the  heating  season,  outdoor  (BaP-TEQ)∑8PAH  and  (BaP-MEQ)∑8PAH  were  significantly  higher  than  the  corresponding  indoor 
measures (Table 2; p < 0.01, Wilcoxon signed ranks test). A similar pattern was not observed during the nonheating season (Table 2; p > 0.05, Wilcoxon 
signed ranks test). Similarly, most individual 8 PAH (except BaP and IP) were higher outdoors compared to indoors during the heating season (p < 0.05). 
BbFA and Chry were significantly higher outdoors than indoors regardless of season (p < 0.05, Wilcoxon signed ranks test).  
 
Table 2. Relationship between indoor and outdoor BaP-equivalent carcinogenicity and mutagenicity risks, stratified by season. 
Season  Measure  Indoor, ng/m
3 
(n
a = 55; n
b = 26) 
  Outdoor, ng/m
3 
(n
a = 55; n
b = 26) 
 
    Average  SD  Median    Average  SD  Median  p 
Heating  (BaP-TEQ)∑8PAH  0.460  0.365  0.346    0.558  0.407  0.485  0.002** 
  (BaP-MEQ)∑8PAH  0.521  0.448  0.388    0.660  0.480  0.500  0.001** 
Nonheating  (BaP-TEQ)∑8PAH  0.515  1.602  0.163    0.232  0.233  0.167  0.989 
  (BaP-MEQ)∑8PAH  0.975  3.826  0.174    0.260  0.230  0.173  0.989 
**(p<0.01) for Wilcoxon Signed Ranks test. 
n
a: Number for heating season, n
b: Number for nonheating season 
Heating season was defined as any sampling that was initiated October 1
st through April 30
st. Int. J. Environ. Res. Public Health 2010, 7                 
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Figure 1. Seasonal variations in (a) (BaP-TEQ)8PAH and (b) (BaP-MEQ)8PAH. 
 
 
Note:  Mann-Whitney  test  was  performed  to  compare  heating  season  and  nonheating 
concentrations (BaP-TEQ)8PAH and (BaP-MEQ)8PAH indoors and outdoors. The white and black 
lines show individual observations, while the white and black area shows the distribution. The 
dotted line indicates the overall geometric mean and the thicker solid line shows the geometric 
mean  concentration  of  indoors  and  outdoors  for  each  season.  Mann-Whitney  test,  **p<0.001. 
8PAH  includes  benz(a)anthracene  (BaA),  chrysene/iso-chrysene  (Chry),  benzo(b)fluoranthene 
(BbFA),  benzo(k)fluoranthene  (BkFA),  benzo(a)pyrene  (BaP),  indeno(1,2,3-c,d)pyrene  (IP), 
dibenz(a,h)anthracene(DahA), and benzo(ghi)perylene (BghiP). Int. J. Environ. Res. Public Health 2010, 7                 
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4. Discussion and Conclusions  
Our objective was to estimate the potential carcinogenic and mutagenic risks of residential exposure 
to PAH for a cohort of inner city young children based on BaP-equivalent concentration (BaP-TEQ and 
BaP-MEQ). We found a significant effect of heating season on BaP-TEQ and BaP-MEQ possibly due 
to higher emissions from heating sources and more frequent stagnant meteorological conditions in the 
winter. While an effect of heating season has been documented in small studies [15,16], this is the first 
paper  to  examine  seasonal  differences  in  carcinogenic  and  mutagenic  risks  based  on  residential 
exposure of a large cohort of urban children.  
The  indoor  (BaP-TEQ)∑8PAH  levels  observed  in  this  study  were  considerably  lower  than  those 
reported for other homes impacted heavily by industrial and traffic emissions in Ohura et al. [15]. 
(BaP-TEQ)∑8PAH  risk  levels  depend not  only  on  concentrations  of individual 8 PAH,  but  also  the 
composition of PAH mixtures affected by varying emission sources. While  8PAH concentrations 
measured  in  the  Ohura  study  were  1.3–2.2  times  higher  than  those  measured  in  this  study,  
(BaP-TEQ)∑8PAH levels were 2–3.5 times higher. Consistent with Ohura et al. [15], we observed that 
BaP  was  the  dominant  compound  contributing  to  (BaP-TEQ)∑8PAH,  accounting  for  45% of indoor 
(BaP-TEQ)∑8PAH and 35% of outdoor (BaP-TEQ)∑8PAH.  
While the contributions of the sum of IP and BghiP to (BaP-TEQ)∑8PAH both indoors and outdoors 
were only 11–12%, their contributions to (BaP-MEQ)∑8PAH were much higher considerably (45–48%). 
Considering that these compounds  are  considered  tracers of vehicular emissions [26], exposure to 
traffic emissions may impact the mutagenicity risk to a greater extent than the carcinogenic risk.  
Both indoors and outdoors, higher (BaP-TEQ)∑8PAH and (BaP-MEQ)∑8PAH risks were observed in 
the heating season, compared to the nonheating season. The heating season may be associated with  
(1)  increased  use  of  fossil  fuel  combustion  for  residential  heating  (2)  reduced  air  exchange  rates 
(AERs) [27], (3) reduced PAH transformation through photochemical/chemical reaction due to a lower 
temperature and ozone concentration [28], (4) gas/particle partitioning in favor of the particulate phase 
with lower temperature and (5) frequent stagnant meteorological conditions such as a lower mixing 
height. Presumably some combination of these characteristics of heating season led to changes in either 
concentrations or relative composition that was pertinent to the calculation of these measures. 
Several  studies  reported  that  heavier  5–7  ring  PAH  have  higher  airborne  measures  outdoors 
compared to  indoors, due to the presence of major outdoor emission sources (i.e., traffic sources, 
industry, and power generation etc) of those compounds [15,29]. Heavier PAH concentrations indoors 
are strongly affected not only by the outdoor concentrations but also by outdoor-to-indoor AERs that 
were  shown  to  be  lower  during  winter  than  summer  when  residential  windows  usually  are  
shut [15,27,29]. Similar trends were obtained for (BaP-TEQ)∑8PAH and (BaP-MEQ)∑8PAH during the 
heating season. This result suggests that children are subjected to higher carcinogenic and mutagenic 
risks derived from PAH when they play outside more so than inside the home during the heating 
season. When compared to other urban outdoor values measured in the winter season [15-17], outdoor 
(BaP-TEQ)∑8PAH  and  (BaP-MEQ)∑8PAH  observed  in  this  study  were  2–5  times  lower  during  the  
heating season. 
These risks measured and calculated here raise significant concerns for public health. For example, 
applying the World Health Organization (WHO) suggested unit risk of 8.7  10
-5 (ng/m
3)
-1 for lifetime Int. J. Environ. Res. Public Health 2010, 7                 
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(70 years) PAH exposure [30], the corresponding lifetime lung cancer risks were found to be 4.2  10
-5 
(= 0.478 ng/m
3  8.7  10
-5 (ng/m
3)
-1) and 5.1  10
-5 (= 0.590 ng/m
3  8.7  10
-5 (ng/m
3)
-1) when the 
average indoor (BaP-TEQ)∑8PAH and (BaP-MEQ)∑8PAH concentration were used, respectively. Hence, if 
1,000,000 people were exposed to 0.478 ng/m
3 of indoor (BaP-TEQ)∑8PAH for 70 years, then 42 people 
may  develop  lung cancer. An excess lung cancer risk from lifetime exposure to  (BaP-MEQ)∑8PAH 
concentration would be 51 cases among one million individuals exposed. The estimated cancer risks 
from air pollution in NYC did not exceed a health-based guideline (8.7  10
-5) calculated based on the 
maximum permissible level of 1 ng/m
3 of BaP [30]. However, it should be noted that the risk estimates 
presented are very uncertain, and could be understood only as a crude estimation of cancer risk from 
the PAH inhalation. 
We acknowledge study limitations. The potential risk of PAH exposure based on TEQ or MEQ may 
be  underestimated  if  the  interaction  of  some  PAHs  are  synergistic  rather  than  additive.  Chemical 
degradation  of  PAH  by  ambient  oxidants  (ozone,  hydroxyl  radical,  or  nitrogen  oxides)  in  the 
atmosphere as well as on the filters during sampling could also underestimate the potential risks due to 
reduced  measured  PAH  levels,  as  shown  in  several  studies  [28,31-36].  For  example,  BaP 
concentrations collected without denuder that can remove atmospheric oxidants such as ozone and OH 
radical  can be underestimated by more than 200% of the measured value at high ozone levels in 
summer  [28,31].  Also  PAH  collected  on  the  filters  may  be  decomposed  through  heterogeneous 
chemical  reactions  with  ozone  during  an  extended  sampling  period  [28,34-36].  Furthermore, 
nitrated/oxygenated PAH compounds have not been measured in this study, underestimating the full 
carcinogenic  and  mutagenic  potential  of  PAH  exposure.  Those  PAH  compounds  formed  by 
photochemical/chemical  reactions  are  known  to  be  more  toxic  than  their  parent  PAH  based  on 
tumorigenicity of PAH in a newborn mouse assay [8,37,38]. Young children can be exposed to PAH 
through other routes besides inhalation. These include ingesting food, nondietary ingestion of dust or 
soil through hand-to-mouth activity, or dermal contact with soil polluted by PAH [39,40]. Although 
inhalation is an important pathway for inner-city children because of high levels of PAH measured in 
indoor and outdoor air, dietary ingestion and non-dietary ingestion pathways are thought to be more 
important for young children’s exposure to heavier PAHs [39,40]. Thus, the values reported in this 
study may need to be considered as the lower limit of estimated potential PAH health risk resulted 
from inhalation of air. Further investigations are needed whether BaP-equivalent levels are associated 
with any observed health outcomes (i.e., respiratory or allergic symptoms etc.) within the cohort. 
In conclusion, we found that heating season is an important contributor to the potential risk of PAH 
exposure. This finding has implications for the design of environmental health studies that focus on air 
pollution exposure and young children living in the inner city.  
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